Balanced news tone
News Sentiment
INSP sentiment intelligence
Inspire Medical Systems Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
+10.2% over one week, +21.2% over four weeks, trend inactive, and below fair value.
Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 16 Jul 2026 13:32
- Source
- marketscreener.com
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 10:54
- Source
- StockStory
Investigation continues into Inspire Medical Systems over delayed product launch and earnings cut.
Kahn Swick & Foti, LLC is investigating Inspire Medical Systems due to delays in launching its Inspire V device and a significant cut in its 2025 earnings guidance. The delays stem from issues like incomplete training, software problems, and excess inventory. Inspire and some exe
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 11 Jul 2026 18:42
- Source
- Pluang
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Inspire Medical Systems, Inc. (NYSE: INSP) and its officers and directors. This follows a previous securities class action lawsuit filed after the company disclosed significant issues with the launch of its Inspire
- Tone
- Negative 29/100
- Event
- Regulatory and legal
- Published
- 11 Jul 2026 02:10
- Source
- PR Newswire
Inspire Medical Systems (INSP) Short Interest & Short Float | Updated Jul 2026 $INSP
Inspire Medical Systems (INSP) experienced a 30.79% increase in short interest, reaching 4.69 million shares sold short as of June 30, 2026. This represents 16.66% of the public float, with a short interest ratio of 3.8 days to cover. The change indicates a growing bearish sentim
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 10 Jul 2026 18:42
- Source
- MarketBeat
Price to sales forward of Inspire Medical Systems, Inc. – NYSE:INSP
This article displays the "Price to sales forward" metric for Inspire Medical Systems, Inc. (NYSE: INSP) on TradingView. It presents financial data for the company, indicating key statistical values over a specific period, and notes that the information was made by humans.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 17:40
- Source
- TradingView
Enterprise value to EBIT forward of Inspire Medical Systems, Inc. – NYSE:INSP
The article displays the enterprise value to EBIT forward for Inspire Medical Systems, Inc. (NYSE: INSP) within the TradingView platform. It presents financial overview information for the company, accessible through various features of the platform like charts, screeners, and ne
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 14:09
- Source
- TradingView
Inspire Medical Systems (INSP) Faces A Fresh Test As Recalls Put Valuation In Focus
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 10 Jul 2026 09:13
- Source
- Simply Wall St.
ETFs Investing in Inspire Medical Systems, Inc. Stocks
This article lists various ETFs that hold stock in Inspire Medical Systems, Inc. The ETFs are sorted by market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price, change, and 3-year NAV total return. The ETFs predominantly focus o
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 22:11
- Source
- TradingView
2 Reasons INSP is Risky and 1 Stock to Buy Instead
Inspire Medical Systems (INSP) shares have dropped significantly, prompting analysis of its future prospects. The article identifies two key risks: limited distribution channels due to its smaller size, hindering economies of scale and trust-building in a regulated industry, and
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 09 Jul 2026 07:11
- Source
- StockStory
Investors in Inspire Medical Systems, Inc. (INSP): Protect Your Rights - Contact Levi & Korsinsky Before January 5, 2026
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Inspire Medical Systems, Inc. (INSP) on behalf of investors who purchased securities between August 6, 2024, and August 4, 2025. The lawsuit alleges that Inspire Medical Systems made false statements and co
- Tone
- Negative 19/100
- Event
- Regulatory and legal
- Published
- 08 Jul 2026 05:10
- Source
- The National Law Review
Inspire Medical Systems (INSP) Could Be 5% Undervalued After Class II Device Recalls
Inspire Medical Systems (INSP) is under scrutiny following Class II device recalls for incorrect labeling, impacting selected units in the US and Hong Kong. Despite this, the stock has recently rebounded by 20.05% after significant year-to-date and one-year declines. A popular na
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Jul 2026 17:40
- Source
- Simply Wall Street
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026
Inspire Medical Systems, Inc. (NYSE: INSP) announced a correction to its previous press release, confirming that its second quarter 2026 financial results will be released after the close of trading on Monday, August 3, 2026. The company's management team will host a conference c
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 05:10
- Source
- GlobeNewswire
Inspire Medical Systems to report Q2 2026 results on August 3
Inspire Medical Systems, Inc. announced it will release its second-quarter 2026 financial results after market close on Monday, August 3, 2026. A conference call will be held at 5:00 p.m. Eastern Time for the management team to discuss the results and recent business developments
- Tone
- Negative 36/100
- Event
- Earnings
- Published
- 06 Jul 2026 19:41
- Source
- scanx.trade
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
Inspire Medical Systems, Inc. announced it will release its second quarter 2026 financial results after the close of trading on Monday, August 3, followed by a conference call at 5:00 p.m. ET to discuss the results and business developments. The company initially provided an inco
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 17:09
- Source
- GlobeNewswire
Inspire Medical corrects Q2 2026 results date to Aug. 3
Inspire Medical Systems (NYSE: INSP) has corrected the date for its second-quarter 2026 financial results release to Monday, August 3, 2026, after market close. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and business d
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 14:13
- Source
- Stock Titan
Inspire Medical sets Aug. 3 earnings call after Q2 results
Inspire Medical Systems (NYSE: INSP) will release its second quarter 2026 financial results after the market close on Monday, August 3, 2026. The company will host a conference call at 5:00 p.m. Eastern Time on the same day to discuss the results and recent business developments.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Jul 2026 12:13
- Source
- Stock Titan
Inspire Medical Systems (INSP) Gets a Hold from Wells Fargo
Wells Fargo analyst Larry Biegelsen maintained a Hold rating for Inspire Medical Systems (INSP) with a price target of $56.00, while the company's shares closed at $46.95. This follows a similar Hold rating from Evercore ISI, though Freedom Capital Markets initiated coverage with
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Jul 2026 16:40
- Source
- The Globe and Mail
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $56
Wells Fargo has reaffirmed its "Hold" rating for Inspire Medical Systems (INSP.US) and maintained its target price at $56. This indicates a neutral outlook on the stock's future performance based on the bank's analysis.
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 04 Jul 2026 04:09
- Source
- Moomoo
Inspire Medical Systems (NASDAQ: INSP) D.E. Shaw affiliate reports 5.1% holding
D. E. Shaw & Co., L.P. and its affiliates have reported a 5.1% beneficial ownership stake in Inspire Medical Systems (NASDAQ: INSP), totaling 1,483,107 shares of common stock. The Schedule 13G filing indicates shared voting power over 1,374,263 shares and shared dispositive power
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 19:40
- Source
- Stock Titan
INSP - Inspire Medical Systems Inc Options
This article provides a detailed financial overview of Inspire Medical Systems Inc (INSP), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance indicators, analyst recommendations, and insider/institut
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 02 Jul 2026 17:09
- Source
- Finviz
INSP Initiates Coverage On Inspire Medical Systems -- Rating Buy
Freedom Capital Markets initiated coverage on Inspire Medical Systems (INSP) with a "Buy" rating and a price target of $62.00, suggesting a significant upside from its current trading price of $44.61. The company is considered undervalued according to GuruFocus's GF Value™ and sh
- Tone
- Positive 82/100
- Event
- Analyst action
- Published
- 01 Jul 2026 12:14
- Source
- GuruFocus
Inspire Medical shares initiated at buy by Freedom Capital on valuation
Freedom Capital has initiated coverage on Inspire Medical Systems Inc. (NYSE:INSP) with a "buy" rating and a price target of $62.00, suggesting a 39% upside from its current price. Despite potential near-term volatility from reimbursement issues and competition, the firm believes
- Tone
- Positive 61/100
- Event
- Analyst action
- Published
- 01 Jul 2026 01:40
- Source
- Investing.com
Inspire Medical Systems, Inc.(NYSE: INSP) added to Russell 2000 Index
Inspire Medical Systems, Inc. (NYSE: INSP) has been added to the Russell 2000 Index, as well as the Russell 2000 Value and Russell 2000 Growth Benchmarks. Simultaneously, the company was dropped from several other Russell indices, including the Russell Midcap Growth, Russell 1000
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 29 Jun 2026 18:39
- Source
- www.marketscreener.com
Inspire Medical Systems, Inc.(NYSE:INSP) dropped from Russell Midcap Growth Benchmark
Inspire Medical Systems, Inc. (NYSE:INSP) has been dropped from the Russell Midcap Growth Benchmark. This news comes alongside several other index changes for the company, including being added to the Russell 2000 Index, Russell 2000 Value Benchmark, and Russell 2000 Growth Bench
- Tone
- Negative 37/100
- Event
- Market update
- Published
- 29 Jun 2026 17:12
- Source
- www.marketscreener.com
Why Inspire Medical Systems (INSP) Is Up 10.6% After Russell Index Reclassification To Small Cap
Inspire Medical Systems (INSP) saw its stock rise by 10.6% after being reclassified from the Russell 1000 to smaller-cap Russell indices like the Russell 2000. This shift may alter its investor base and position sizing, though the underlying investment narrative for its obstructi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 15:40
- Source
- Sahm
Inspire Medical Systems (INSP) shares June 26, 2026 investor presentation via 8-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Stock Titan
Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
Evercore ISI Downgrades Inspire Medical Systems to In Line From Outperform, Adjusts PT to $40 From $55
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 23 Jun 2026 10:57
- Source
- MT Newswires
This Undervalued Medical-Devices Stock Is Poised for a Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Barron's